All stock lists
Pan American Silver Corp. (New York Stock Exchange:PAAS)
CA · Delayed Price · Currency is USD
Also listed: PAAS.TO, 0R07.LBasic Materials · Gold
$37.72-$1.62 (-4.12%)
Market cap
$15.6B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 12, 1995
Website
Insider Score
––Not scored
PAAS Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From PAAS’s reported statements · Q3 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $4.45B
- Net income
- $1.57B
- Net margin
- 35.2%
Leverage20 / 20
Little or no net debt.
- Total debt
- $844.0M
- Cash
- $1.51B
- Net debt / EBITDA
- -0.25x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $2.58B
- Current liabilities
- $949.0M
- Current ratio
- 2.72
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $1.99B
- Free cash flow
- $1.57B
- FCF margin
- 35.4%
Dilution & runway12 / 20
Some dilution over the past year.
- Shares outstanding
- 414.7M
- Share growth (1y)
- 9.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PAAS Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $1.01 B | $1.10 B | $1.15 B | $1.20 B | $854.60 M | $811.90 M |
| Revenue Growth (YoY) | 17.72 % | 34.93 % | 49.25 % | 46.91 % | 19.34 % | 18.30 % |
| Cost of Revenue | $633.00 M | $664.68 M | $546.00 M | $632.17 M | $541.60 M | $538.60 M |
| Gross Profit | $373.00 M | $430.78 M | $608.00 M | $565.26 M | $313.00 M | $273.30 M |
| SG&A Expense | $25.00 M | $17.54 M | $39.00 M | $39.09 M | $31.40 M | $21.60 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $26.00 M | $24.37 M | $48.00 M | $96.26 M | $63.30 M | $29.40 M |
| Operating Income | $347.00 M | $406.41 M | $560.00 M | $469.00 M | $249.70 M | $243.90 M |
| Pretax Income | $462.00 M | $471.71 M | $641.00 M | $548.91 M | $249.10 M | $234.40 M |
| Tax Provision | $105.00 M | $174.45 M | $185.00 M | $90.06 M | $79.90 M | $44.80 M |
| Net Income | $357.00 M | $296.28 M | $457.00 M | $458.44 M | $168.60 M | $189.20 M |
| EPS (Basic) | $0.86 | $0.70 | $1.08 | $1.09 | $0.44 | $0.52 |
| EPS (Diluted) | $0.86 | $0.70 | $1.08 | $1.09 | $0.44 | $0.52 |
| Shares Outstanding | 414.65 M | 420.27 M | 421.85 M | 422.05 M | 378.82 M | 362.01 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.